Adiposity and Cumulative Cardiometabolic Risk Factors as Determinants of Hepatic Steatosis Severity in Postmenopausal Women
Journal of Clinical Medicine · 05.08.2026 · 15 (15) · 6098
DOI: 10.3390/jcm15156098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.08.2026. Verfasst von Ifigeneia Avgousti und 11 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 11528 Athens, Greece. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Postmenopausal women are at increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD). This study evaluated the associations of anthropometric and hormonal parameters and cardiometabolic risk-factor accumulation with steatosis and MASLD.
Methods
In this cross-sectional study, 87 postmenopausal women at a university menopause clinic underwent anthropometric, biochemical, and liver imaging assessment. Hepatic steatosis was defined as CAP ≥ 248 dB/m on transient elastography, and MASLD as steatosis with ≥1 cardiometabolic risk factor (2023 consensus criteria). Anthropometry included body mass index (BMI), waist circumference, mid-upper arm circumference, and triceps skinfold thickness.
Results
CAP-defined steatosis (46.0%) closely mirrored MASLD (44.8%; all but one steatotic woman met ≥ 1 criterion). Waist circumference independently correlated with steatosis (OR = 2.77, 95% CI 1.08–7.13, p = 0.035), adding value beyond BMI (Nagelkerke R2 0.202 vs. 0.140). Steatosis burden rose progressively with risk-factor number: each additional factor conferred a 30.59 dB/m CAP increase (95% CI 17.33–43.85, p < 0.001) and 3.38-fold higher odds of steatosis (95% CI 1.59–7.20, p = 0.002; ≥3 vs. 2 factors, Welch’s p = 0.004).
Conclusions
MASLD and CAP-defined steatosis were largely coincident. Adiposity correlated with steatosis, but severity was determined chiefly by the accumulation of cardiometabolic risk factors, which is a key determinant of steatotic liver disease severity after menopause.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Aretaieio Hospital, 11528 Athens, Greece.
- 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece.
- 3rd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- 1st Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", 11527 Athens, Greece.
ORCID-Profile: Eleni Armeni, Dimitrios S Karagiannakis, Sofia Kalantaridou, George Papatheodoridis, Makarios Eleftheriadis
Zitieren
APA
Avgousti, I., Augoulea, A., Armeni, E., Karagiannakis, D. S., Paraskevopoulou, S., Panoulis, K., Kalantaridou, S., Papanikola, N., Angelopoulou, A., Papatheodoridis, G., Eleftheriadis, M., & Lambrinoudaki, I. (2026). Adiposity and Cumulative Cardiometabolic Risk Factors as Determinants of Hepatic Steatosis Severity in Postmenopausal Women. Journal of Clinical Medicine, 15(15), 6098. https://doi.org/10.3390/jcm15156098
Vancouver
Avgousti I, Augoulea A, Armeni E, Karagiannakis DS, Paraskevopoulou S, Panoulis K, et al. Adiposity and Cumulative Cardiometabolic Risk Factors as Determinants of Hepatic Steatosis Severity in Postmenopausal Women. Journal of Clinical Medicine. 2026;15(15):6098. doi:10.3390/jcm15156098
BibTeX
@article{Avgousti2026,
author = {Avgousti, Ifigeneia and Augoulea, Areti and Armeni, Eleni and Karagiannakis, Dimitrios S and Paraskevopoulou, Sofia and Panoulis, Konstantinos and Kalantaridou, Sofia and Papanikola, Nektaria and Angelopoulou, Anastasia and Papatheodoridis, George and Eleftheriadis, Makarios and Lambrinoudaki, Irene},
title = {Adiposity and Cumulative Cardiometabolic Risk Factors as Determinants of Hepatic Steatosis Severity in Postmenopausal Women},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {6098},
doi = {10.3390/jcm15156098}
}
EUVIMED